DG DISPATCH - APS: Osteoarthritis Pain Relieved By Topical Civamide
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




DG DISPATCH - APS: Osteoarthritis Pain Relieved By Topical Civamide

By Mona Hughes
Special to DG News

FORT LAUDERDALE, FL -- October 25, 1999 -- New research shows topical civamide is effective in reducing pain associated with primary, post-traumatic osteoarthritis of the knee.

The researchers were Joel E. Bernstein and Scott B. Phillips, of Winston Laboratories; Rashid Khairi, of Physicians Research Group; and Charles Birbara, of Clinical Pharmacology Study Group. The researchers studied civamide (cis-8-methyl-N-vanilly1-6-nonenamide), a vanilloid receptor agonist and neuronal calcium channel blocker that inhibits the release of excitatory neurotransmitters and depletes neurons of their neuropeptide contect.

In a double-blind, vehicle-controlled, parallel study, researchers recruited 179 patients (at least 40 years of age) with moderate to severe, primary or post-traumatic osteoarthritis (OA) of the knee. They applied either 0.075 percent civamide cream or cream vehicle QID to the knees for four weeks.

The results show that, after seven days of treatment, civamide-treated patients had nearly a 40 percent reduction in pain, evaluated by the visual analogue scale (VAS). After four weeks of treatment, pain was reduced by a mean of 55 percent, with statistically significant reductions in knee pain observed for civamide treated joints versus those treated with vehicle for all four efficacy variables measured.

The investigators reported that the only side effect associated with civamide was transient burning and stinging reactions at the application sites. They concluded that civamide 0.075 percent cream is a safe and effective treatment for pain associated with OA of the knees.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities